pubmed-article:1055383 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1055383 | lifeskim:mentions | umls-concept:C0162573 | lld:lifeskim |
pubmed-article:1055383 | lifeskim:mentions | umls-concept:C0205103 | lld:lifeskim |
pubmed-article:1055383 | lifeskim:mentions | umls-concept:C0035668 | lld:lifeskim |
pubmed-article:1055383 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:1055383 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1055383 | pubmed:dateCreated | 1975-7-14 | lld:pubmed |
pubmed-article:1055383 | pubmed:abstractText | Pseudomonas phaseolicola infected with bacteriophage phi 6 synthesized all three viral double-stranded RNA segments, three single-stranded RNAs, and three replicative intermediate-like RNAs in the presence of rifampin. The single-stranded RNA intermediates sedimented and electrophoresed along with melted viral double-stranded RNA, annealed with melted viral double-stranded RNA, and were transient in nature. The relative amounts of the single-stranded RNA intermediates varied during the infection cycle and were altered in the presence of chloramphenicol. The replicative intermediate-like RNAs sedimented faster than double-stranded RNA, failed to enter 2.5% polyacrylamide gels, eluted with double-stranded RNA from a CF-11 cellulose column, were precipitated with single-stranded RNA in 2 M LiC1, and yielded three genome-size pieces of double-stranded RNA upon digestion with RNase. These results are consistent with the hypothesis that complementary strands of the phi 6 double-stranded RNAs are synthesized asynchronously during the infection cycle. | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:language | eng | lld:pubmed |
pubmed-article:1055383 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1055383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1055383 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1055383 | pubmed:month | Mar | lld:pubmed |
pubmed-article:1055383 | pubmed:issn | 0027-8424 | lld:pubmed |
pubmed-article:1055383 | pubmed:author | pubmed-author:VidaverA KAK | lld:pubmed |
pubmed-article:1055383 | pubmed:author | pubmed-author:Van EttenJ... | lld:pubmed |
pubmed-article:1055383 | pubmed:author | pubmed-author:CoplinD LDL | lld:pubmed |
pubmed-article:1055383 | pubmed:author | pubmed-author:KoskiR KRK | lld:pubmed |
pubmed-article:1055383 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1055383 | pubmed:volume | 72 | lld:pubmed |
pubmed-article:1055383 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1055383 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1055383 | pubmed:pagination | 849-53 | lld:pubmed |
pubmed-article:1055383 | pubmed:dateRevised | 2010-9-3 | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:meshHeading | pubmed-meshheading:1055383-... | lld:pubmed |
pubmed-article:1055383 | pubmed:year | 1975 | lld:pubmed |
pubmed-article:1055383 | pubmed:articleTitle | Intermediates in the biosynthesis of double-stranded ribonucleic acids of bacteriophage phi 6. | lld:pubmed |
pubmed-article:1055383 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1055383 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1055383 | lld:pubmed |